This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Mitsubishi Tanabe Pharma Corporation, Tanabe Seiyaku Company, Limited. Active years: 2006-2009.
Location History:
- Osaka, JP (2008)
- Ibaraki, JP (2006 - 2009)
Company Filing History:
2 out of 263 
1 out of 324 Years Active: 2006-2009
Title: Hidetoshi Asai: Innovator in Piperidine Compounds
Introduction
Hidetoshi Asai is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of chemistry, particularly in the development of piperidine compounds. With a total of 3 patents to his name, Asai's work has implications in pharmaceuticals and chemical synthesis.
Latest Patents
Asai's latest patents include innovative piperidine compounds. One of his inventions provides a novel piperidine compound characterized by a specific formula, where Ring A and Ring B represent optionally substituted benzene rings. The compound also includes various substituents such as alkyl groups and hydroxyl groups, which enhance its potential applications. Another patent focuses on the process for preparing these piperidine compounds, further showcasing his expertise in this area.
Career Highlights
Throughout his career, Hidetoshi Asai has worked with prominent companies in the pharmaceutical industry. He has been associated with Mitsubishi Tanabe Pharma Corporation and Tanabe Seiyaku Company, Limited, where he has contributed to various research and development projects. His work has been instrumental in advancing the understanding and application of piperidine compounds.
Collaborations
Asai has collaborated with esteemed colleagues in his field, including Masami Takahashi and Tsutomu Miyake. These collaborations have fostered innovation and have led to the successful development of new chemical compounds.
Conclusion
Hidetoshi Asai's contributions to the field of piperidine compounds highlight his role as an influential inventor. His patents and collaborations reflect his commitment to advancing chemical research and development.